Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Amortization of Goodwill (2024 - 2025)

Historic Amortization of Goodwill for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Q2 2025 value amounting to $30.4 million.

  • Maravai Lifesciences Holdings' Amortization of Goodwill changed N/A to $30.4 million in Q2 2025 from the same period last year, while for Sep 2025 it was $209.1 million, marking a year-over-year increase of 3555.85%. This contributed to the annual value of $166.2 million for FY2024, which is N/A changed from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Amortization of Goodwill stood at $30.4 million for Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Amortization of Goodwill ranged from a high of $166.2 million in Q4 2024 and a low of $12.4 million during Q1 2025